ExoDx Prostate Non-Invasive Test May Eliminate Unnecessary Prostate Biopsies, Study Says

ExoDx Prostate Non-Invasive Test May Eliminate Unnecessary Prostate Biopsies, Study Says
Exosome Diagnostics revealed positive clinical results evaluating its urine-based prostate cancer liquid biopsy test called ExoDx Prostate (IntelliScore). The study, “A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy,” published in JAMA Oncology, indicates the novel test could eliminate the need for tissue biopsies, supporting the value of investing in research targeting Exosomal RNA for diagnostic and patient screening applications. Exosome, who first presented the results at the 2015 American Urological Association (AUA) Annual Meeting, plans to launch the RNA-based tes
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *